Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tecfidera in Relapsing-Remitting Multiple Sclerosis
NCT00420212Phase 3Completed
- Sponsor
- Biogen
- Start
- Jan 2007
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 29
01
Overview
A Phase 3 trial of dimethyl fumarate in relapsing-remitting multiple sclerosis (RRMS), sponsored by Biogen. Started Jan 2007; status: completed.
02
Drugs
dimethyl fumarate
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT00420212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00420212.